98953-13-0

Usage

Uses

Used in Corrosion Inhibition:
2,3-Dihydro-1,4-benzodioxine-6-carbohydrazide is used as a corrosion inhibitor in boiler systems, where it helps to prevent the degradation of metal surfaces that can be caused by chemical reactions with water and other substances.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 2,3-Dihydro-1,4-benzodioxine-6-carbohydrazide serves as a chemical intermediate, playing a crucial role in the synthesis of various pharmaceuticals due to its reactive chemical groups.
Used in Agricultural Chemicals:
Similarly, in the agricultural sector, it is utilized as an intermediate in the production of agricultural chemicals, contributing to the development of products that enhance crop protection and yield.
Used in Organic Synthesis:
2,3-Dihydro-1,4-benzodioxine-6-carbohydrazide is also employed in the synthesis of organic compounds, where its chemical structure allows for the creation of a wide range of molecules with different applications.
Used in Textile and Paper Industries:
In the textile and paper industries, it functions as a reducing agent, which is essential for certain processes, such as dyeing and finishing of textiles, and the bleaching of paper products.
Used in Explosives Manufacturing:
Carbohydrazide has applications in the manufacture of explosives, where its properties are harnessed to create compounds with specific detonation characteristics.
Used in Photographic Industry:
It is also used as a stabilizer for color photographic developing agents, ensuring the quality and longevity of the developed images.
Safety Precautions:
Given its diverse applications, it is imperative to handle 2,3-Dihydro-1,4-benzodioxine-6-carbohydrazide with care and adhere to proper safety measures, as it is classified as a hazardous substance.

InChI:InChI=1/C9H10N2O3/c10-11-9(12)6-1-2-7-8(5-6)14-4-3-13-7/h1-2,5H,3-4,10H2,(H,11,12)

Upstream product

• 2150-43-8 3,4-dihydroxybenzoic acid methyl ester 
• 4442-54-0 2,3-dihydro-1,4-benzodioxin-6-carboxylic acid 
• 99-50-3 3,4-Dihydroxybenzoic acid 
• 20825-87-0 2,3-dihydrobenzo[1,4]dioxine-6-carboxylic acid ethyl ester 
• 20197-75-5 2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid methyl ester 

Downstream Products

• 1338597-16-2 3-(benzylthio)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-4H-1,2,4-triazole 
• 1338597-17-3 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(2-nitrobenzylthio)-4-phenyl-4H-1,2,4-trazole 
• 1338597-18-4 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(3-nitrobenzylthio)-4-phenyl-4H-1,2,4-trazole 
• 1338597-19-5 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(4-nitrobenzylthio)-4-phenyl-4H-1,2,4-trazole 
• 1338597-20-8 3-(2-chlorobenzylthio)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-4H-1,2,4-triazole 
• 1338597-21-9 3-(3-chlorobenzylthio)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-4H-1,2,4-triazole 
• 1338597-22-0 3-(4-chlorobenzylthio)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-4H-1,2,4-triazole 
• 1338597-23-1 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(3-methoxybenzylthio)-4-phenyl-4H-1,2,4-triazole 
• 1338597-24-2 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(2-methylbenzylthio)-4-phenyl-4H-1,2,4-triazole 
• 1338597-25-3 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(4-methylbenzylthio)-4-phenyl-4H-1,2,4-triazole 
• 1338597-26-4 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(2-fluorobenzylthio)-4-phenyl-4H-1,2,4-triazole 
• 1338597-27-5 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-(4-fluorobenzylthio)-4-phenyl-4H-1,2,4-triazole 
• 1338597-28-6 3-(2,4-difluorobenzylthio)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-4H-1,2,4-triazole 
• 1338597-29-7 3-(2,6-difluorobenzylthio)-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-4-phenyl-4H-1,2,4-triazole 

Relevant academic research and scientific papers

Surveying heterocycles as amide bioisosteres within a series of mGlu7 NAMs: Discovery of VU6019278

This letter describes a diversity-oriented library approach to rapidly assess diverse heterocycles as bioisosteric replacements for a metabolically labile amide moiety within a series of mGlu7 negative allosteric modulators (NAMs). SAR rapidly

Synthesis and in vivo Anti-inflammatory Evaluation of Piperazine Derivatives Containing 1,4-Benzodioxan Moiety

Six piperazine derivatives 6a–f containing 1,4-benzodioxan moiety have been synthesized and characterized by 1H NMR, ESI-MS and elemental analysis. The structure of 6d was further confirmed by single crystal X-ray diffraction. All these novel c

Characterization and Crystal Structure of a Novel Mononuclear Cobalt(II) Complex with Hydrazone Derived from Protocatechuic Acid

A novel complex [CoII(L)2·CH3OH] with hydrazone derived from protocatechuic acid (HL=C16H14N2O4) is designed and synthesized. The complex is characterized by single crystal X-ray

Synthesis, Biological Evaluation, and Molecular Docking of 1,4-Benzodioxan Derivatives as Potential Antibacterial Agents

A series of novel 1,4-benzodioxan derivatives containing Schiff base are synthesized by the method of splicing active substructures. All compounds are assayed for antimicrobial activity. The preliminary results indicate that most of the products demonstrate higher antibacterial activity against Gram-negative bacteria strains than Gram-positive bacteria strains. Compounds 4d and 4m exhibit better antibacterial activity against E. coli (MIC = 0.78 and 0.17 μg/mL), respectively; compound 4g displays better antibacterial activity against P. aeruginosa (MIC = 0.78 μg/mL). Eleven common antibacterial targets are selected for molecular docking of target compounds. The results demonstrate that all target compounds have the strongest binding energy to Tyrosine-tRNA synthetase (-CDOCKER_INTERACTION_ENERGY, kcal/mol: 47.1486 and 47.3776). Therefore, it is speculated that the target compounds can be used as novel tyrosine-tRNA synthetase inhibitors.

Discovery of a series of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton as potential FAK inhibitors

Focal adhesion kinase (FAK) is an important drug target that plays a fundamental role in mediating signal transduction system. We report herein the discovery of a novel class of 1,3,4-oxadiazole-2(3H)-thione derivatives containing piperazine skeleton with

Synthesis, biological evaluation, and molecular docking studies of diacylhydrazine derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents

A series of diacylhydrazine derivatives containing 1,4-benzodioxan 1-17 has been designed, synthesized and evaluated for antitumor activity. Most of the synthesized compounds demonstrated potent antitumor activity and low toxicity. Compound 10 demonstrate

Oxadiazole-containing piperazine derivative as well as preparation method and use thereof

The invention belongs to the technical field of organic synthesis, and particularly relates to an oxadiazole-containing piperazine derivative as well as a preparation method and use thereof. The oxadiazole-containing piperazine derivative provided by the

Synthesis, structure, and urease inhibitory activities of Co(III), Mn(II) and Zn(II) complexes with hydrazone derived from protocatechuic acid

[CoIII(L1)2·H2O]NO3 (1), [MnII(L1)2·H2O] (2), and [ZnII(L1)2·H2O] (3) with a hydrazone derived from protocatechu

Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors

A novel class of aromatic diacylhydrazine derivatives was designed as PLK1 inhibitors. All the 19 new synthesized compounds were assayed for antitumor activity against the respective cervical cancer cells. In which, nine compounds with better antitumor activities were further tested for their PLK1 inhibitory activity. Last, we have successfully found that compound 7k showed both the promising antitumor activity with IC50 of 0.17 μM against the cervical cancer cells, and also processed the most potent PLK1 inhibitory activity with IC50 of 0.03 μM. In addition, docking simulation also carried out in this study to give a potent prediction binding mode between the small molecule and PKL1 (PDB code: 1umw) protein.

Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent ss-Ketoacyl-acyl carrier protein synthase III (FabH) inhibitor

Fatty acid biosynthesis is essential for bacterial survival. ss-Ketoacyl-acyl carrier protein (ACP) synthase III (FabH), is a particularly attractive antibacterial target, since it is central to the initiation of fatty acid biosynthesis. Three series of 2